Reversible epigenetic alterations regulate class I HLA loss in prostate cancer.
Rodems TS, Heninger E, Stahlfeld CN, Gilsdorf CS, Carlson KN, Kircher MR, Singh A, Krueger TEG, Beebe DJ, Jarrard DF, McNeel DG, Haffner MC, Lang JM.
Rodems TS, et al.
Commun Biol. 2022 Sep 1;5(1):897. doi: 10.1038/s42003-022-03843-6.
Commun Biol. 2022.
PMID: 36050516
Free PMC article.